Skip to main content
Profile picture for Jack Cush, MD

Jack Cush, MD

Dr. Cush is the Executive Editor of RheumNow.com and also Co-Edits the online textbook RheumaKnowledgy.com. 
  
Dr. Cush's interests include medical education, novel drug development, rheumatoid arthritis, spondyloarthritis, drug safety, and Still's disease/autoinflammatory syndromes. He has published over 140 articles and 2 books in rheumatology.
 
He can be followed on twitter: @RheumNow

Articles By Jack Cush, MD

Glenn_Frey.jpg (keep)

10 Ways Rheumatoid Arthritis Could’ve Killed Glenn Frey

I was truly stunned Monday when it was announced that Glenn Frey, from the Eagles, had died as a result of complications from his rheumatoid arthritis, ulcerative colitis and pneumonia.

Read Article
pills-384846_640%20%281%29.jpg

Methotrexate Nonadherence is Common

Researchers from Belgium studied patient adherence to MTX (given orally or via injection) in 129 rheumatoid arthritis (RA) patients over a 16-week period using an electronic monitoring system and two validated adherence questionnaires.

Read Article
15590443_s_0.jpg

French Cannibinoid Phase I Study Gone Wrong

Six volunteers were admitted to the University Hospital of Rennes in France last week after partaking in the Phase I trial of a new medication meant to treat mood disorders such as anxiety.

Read Article
DSB.pill2__0.jpg

DSB Reports & Updates - January 2016

Comparative Harmful Risks with Targeted Immunomodulators. Desai et al did a systematic review of the literature, findings of 10 head-to-head RCTs and 51 observational studies.

Read Article
knee2_0.JPG (keep)

MRI Bone Marrow Lesions Predict Worse Outcomes in Osteoarthritis

Medical Research Council study shows MRI lesions may predict which patients will have more rapidly progressing osteoarthritis. 

Read Article
mosquito.jpg

Mosquito Born Zika Virus Affects Caribbean and Latin America

The Centers for Disease Control and Prevention (CDC) has issued a travel advisory for individuals traveling to the Caribbean and Latin America where infection with Zika virus has been prevalent.

Read Article
approved-160121__180.png

FDA Approves Cosentyx for Ankylosing Spondylitis and Psoriatic Arthritis

Cosentyx (secukinumab) was approved by the FDA on 15 January, 2016 for patients with active ankyosing spondylitis (AS) and psoriatic arthritis (PsA).

Read Article
Preg2_0.jpg

BSR Issues DMARD Prescribing Guidelines for Pregnancy

Treatment paradigms for managing pregnancy in rheumatoid arthritis (RA) have been challenged in recent years with the introduction of new agents and reclassification of drug safety during pregnancy by the FDA.

Read Article
glomerulonephritis.jpg

Ominous Outcomes for Lupus Nephritis

Hanly and coworkers have reported the results of a large lupus cohort study involving 1827 patients. SLE patients were enrolled early in their disease (0.5 years) and were followed for a mean of 4.6 years.

Read Article
narcotics_0.jpg

ACP Backs New CDC Guideline for Opioids and Chronic Pain

Wayne J Riley, MD, MPH, MBA, MACP, president of the American College of Physicians (ACP) sent a letter to the Centers for Disease Control and Prevention (CDC) reacting to its Draft Guideline for the Use of Opioids for Chronic Pain.

Read Article
×